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Abstract
Background: The Janus kinase-signal transducer and activator of transcription (JAK/STAT) pathway has been well-
characterized as a crucial signal transduction cascade that regulates vital biological responses including
development, immunity and oncogenesis. Additionally to its canonical pathway that uses the phosphorylated form
of the STAT transcription factor, recently the non-canonical pathway involving heterochromatin formation by
unphosphorylated STAT was recently uncovered. Considering the significant role of the JAK/STAT pathway, we used
the simple Drosophila system in which the non-canonical pathway was initially characterized, to compare putative
canonical versus non-canonical transcriptional targets across the genome. We analyzed microarray expression
patterns of wildtype, Jak gain- and loss-of-function mutants, as well as the Stat loss-of-function mutant during
embryogenesis, since the contribution of the canonical signal transduction pathway has been well-characterized in
these contexts. Previous studies have also demonstrated that Jak gain-of-function and Stat mutants counter
heterochromatin silencing to de-repress target genes by the non-canonical pathway.
Results: Compared to canonical target genomic loci, non-canonical targets were significantly more associated with
sites enriched with heterochromatin-related factors (p = 0.004). Furthermore, putative canonical and non-canonical
transcriptional targets identified displayed some differences in biological pathways they regulate, as determined by
Gene Ontology (GO) enrichment analyses. Canonical targets were enriched mainly with genes relevant to
development and immunity, as expected, whereas the non-canonical target gene set mainly showed enrichment of
genes for various metabolic responses and stress response, highlighting the possibility that some differences may
exist between the two loci.
Conclusions: Canonical and non-canonical JAK/STAT genes may regulate distinct and overlapping sets of genes
and may perform specific overall functions in physiology. Further studies at different developmental stages, or using
distinct tissues may identify additional targets and provide insight into which gene targets are unique to the
canonical or non-canonical pathway.
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Background
The Janus kinase-signal transducer and activator of tran-
scription (JAK/STAT) signaling pathway was originally
characterized in mammals as an intracellular signaling
pathway regulating cytokine signaling [1–5] and was
later found to be highly conserved in various organisms,
including Drosophila [6–9]. Four JAKs and seven STAT
gene products have been identified in mammals,
whereas in Drosophila, the pathway components are
comprised of simply one JAK and one STAT, making it
an excellent model system to study their biological roles
[8, 10]. In both mammals and Drosophila, the canonical
signaling is initiated by the binding of an extracellular
ligand to transmembrane receptors that induce
dimerization and activate the JAKs associated with these
receptors. Then, the activated JAKs phosphorylate tyro-
sine residues on the cytoplasmic tails of the receptors
that serve as docking sites for cytoplasmic STAT tran-
scription factors, which then are phosphorylated,
dimerize and translocate to the nucleus to activate tran-
scription of target genes [11–13]. It has been well-
established across various species that the canonical
JAK/STAT pathway performs essential roles in develop-
ment, immune signaling and cancers by its direct tran-
scriptional activation of target genes [8, 14–18].
The non-canonical JAK/STAT pathway was initially
identified in Drosophila, in which both the STAT tran-
scription factor and the protein inhibitor of activated
STAT homologue (dPIAS) were found to be suppressors
of variegation, a heterochromatin-mediated phenomenon
[19–21]. Heterochromatin-mediated gene silencing mech-
anisms involving the main non-histone key protein, Het-
erochromatin Protein 1a (HP1a), otherwise known as
Suppressor of varigation 205 (Su(var)205) in Drosophila,
is highly conserved across species [19, 22, 23]. HP1a rec-
ognizes and is recruited to specific genomic loci by di-
and tri-methylated histone 3 lysine 9 (H3K9), which is
regulated by the Su(var)3–9 methyltransferase [22, 24, 25].
The biological role of such non-canonical JAK/STAT
pathway was first meticulously characterized in a tumor
model of Drosophila, in which unphosphorylated STAT
was found to exist in the nucleus and to have the ability to
stabilize heterochromatin and suppress tumor growth [12,
19, 26]. Moreover, it was found that heterochromatin for-
mation and stabilization by unphosphorylated STAT pro-
tects genome stability [27] and prolongs lifespan [28]. The
pivotal role of unphosphorylated STAT in heterochroma-
tin maintenance and tumor suppression was also recapitu-
lated in mammals [29]. Other groups have reported that
unphosphorylated STAT proteins can translocate to and
prominently exist in the nucleus in various mammalian
cells at quiescence, when STAT proteins are not phos-
phorylated [30–35]. Several studies have demonstrated
functions of STAT1, STAT3, STAT5 and STAT6 in
mammals that involve mechanisms that are distinct to
their well-established canonical transcriptional pathway
[36–45]. Additional studies have characterized the in-
volvement of the linker histone H1 in non-canonical JAK/
STAT mechanisms, further suggesting the central role of
unphosphorylated STAT in epigenetic regulation [46]. In
Drosophila, a connection between JAK/STAT signaling
and chromatin remodeling has also been suggested by the
finding that the transcriptional repressor Ken that recruits
a nucleosome remodeling factor (NURF), shares binding
sequences to suppress STAT-mediated transcription of in-
nate immune genes [47]. The epigenetic control of hetero-
chromatin formation and remodeling are crucial for key
nuclear processes including gene silencing, chromosomal
packaging and segregation during mitosis, genome stabil-
ity and cell differentiation [27, 48, 49]. Additionally to its
biological role in oncogenesis, heterochromatin mainten-
ance in Drosophila was found to mediate lifespan [28] and
stem cell maintenance [50], as well as implicated in mam-
malian aging [51]. These observations further underline
the crucial role of the non-canonical JAK/STAT pathway
in various vital biological processes, additionally to its
formerly established canonical signal transduction
mechanisms.
Considering the well-established role of the canonical
JAK/STAT signaling cascade and the recent
characterization of non-canonical JAK/STAT that is dis-
tinct and appear to perform specific roles in physiology
and pathogenesis, it is important to identify target genes
and genomic loci that may be regulated by one or the
other. While there are previous studies that have under-
taken a systematic approach to uncover JAK/STAT path-
way regulators [52, 53], there has not been a study
addressing differences and similarities between canonical
and non-canonical targets. We therefore took a genome-
wide approach to identify target loci pertaining to each,
using Drosophila as a simple model system, in which
both the canonical and non-canonical JAK/STAT have
been particularly well-characterized. We analyzed
genome-wide transcriptional targets of the Jak gain- and
loss-of-function mutants, and the Stat loss-of-function
mutant during embryogenesis, as previous studies have
addressed the role of the canonical signal transduction
in these mutants and furthermore, it has also been found
that Jak gain-of-function and Stat loss-of-function mu-
tants counter heterochromatin silencing to de-repress
target genes by the non-canonical pathway [19, 26]. We
found non-canonical targets to correlate with increased
overlaps with the distribution of HP1a, Su(var)3–9 and
H3K9me3, which are hallmarks of heterochromatin for-
mation. Moreover, our study demonstrates that while ca-
nonical targets tend to be enriched with genes relevant
to development and immune response, non-canonical
target genes tend to be more enriched with GO terms
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related to metabolism and stress response, thus possibly
revealing a previously unidentified putative link between
the non-canonical JAK/STAT pathway and metabolism
and stress response, mediated by heterochromatin. We
therefore conclude that a significant number of distinct
canonical and non-canonical targets appear to exist,
additionally to overlapping processes and loci. Further
experimental results comparing transcriptome alter-
ations in conjunction with chromatin immunoprecipita-
tion from the same embryonic samples will be beneficial
for confirming the conclusions from these analyses.
Results
Analysis of various JAK/STAT mutant embryo
transcriptome changes relative to wildtype show
clustering based on genotype and embryo stage
We collected early Drosophila embryos (0–12 h eggs) from
the following four different genotypes: Jak gain- (hopTum-l/
+), and loss-of-function (hop3/+), Stat loss-of-function het-
erozygotes (Stat92E06346/+), and the Stat loss-of-function
maternal null (Stat92Emat-). We conducted microarray ex-
periments to compare the transcriptome of these embryos
(Additional file 1: Table S1). Gene expression levels were
calculated as fold changes relative to wildtype (w1118) em-
bryos of the same stage. Hierarchical clustering analyses in-
dicated that hopTum-l/+ and Stat92Emat- embryos were most
dissimilar, with many genes expressed in the opposite
manner (Fig. 1A), consistent with gain- and loss-of-
function of the JAK/STAT pathway. Analysis of differen-
tially regulated probe sets found clustering of hopTum-l/+
and hop3/+ together, then Stat92E06346/+, and Stat92Emat-
(Fig. 1A; Additional file 2: Table S2). Next, we assessed the
number of overlapping probe sets between Stat92Emat- and
Stat92E06346/+ upregulated and downregulated sets of genes
(Additional file 3: Table S3). For the upregulated probe sets
there were 49 that were shared between the 381 Stat92E-
mat- and 579 Stat92E06346/+ and for the downregulated set,
there were 47 that were shared between the 788 Stat92E-
mat- and 640 Stat92E06346/+ significantly downregulated
probe sets (Fig. 1B). Since Stat92E06346/+ heterozygous em-
bryos are expected to undergo normal development in spite
of reduced Stat gene activity, the difference between the
transcriptomes of Stat92Emat- and Stat92E06346/+ might be
due to a failure in activation of the zygotic genome in Sta-
t92Emat- embryos, as we have previously shown [54]. The
differentially regulated genes include many of the known
canonical JAK/STAT pathway targets genes, such as the
Turandot (Tot) family of humoral factors [55] (Additional
file 2: Table S2). We validated the differential expression of
several of these known JAK/STAT target genes using RT-
PCR in the hopTum-l/+ overexpression mutants compared to
wildtype (Additional file 4: Fig. S1). These results suggest
that the activation status and levels of JAK and STAT affect
the transcriptome of the early Drosophila embryo. In our
Fig. 1 Hierarchical clustering of Jak gain-of-function and Stat loss-of-function mutants show separation by gene and stage of the embryo. (a) Dif-
ferentially regulated genes were clustered by Pearson’s correlation complete distance separation. (b) Overlaps between Stat92Emat- and
Stat92E06346/+ embryos were determined and suggest that a large number of genes are regulated stage-specifically
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previously published publication, we have validated reduced
expression in the early loss-of-function embryo of the dpp,
Kr, tll, and eve target genes that we have also found in our
current microarray analysis [54].
Canonical versus non-canonical JAK/STAT targets can be
inferred from differential transcriptional analyses across
the genome of various mutants
A hallmark of the noncanonical STAT pathway is that
loss of STAT and JAK overactivation both result in re-
duced heterochromatin levels and previously demon-
strated to be relevant in multiple heterochromatin-
involved processes [26–28]. Thus, genes normally re-
pressed by heterochromatin would be depressed as a re-
sult of reduced heterochromatin. These studies showed
that in contrast, in the canonical pathway, loss of STAT
and JAK overactivation have opposite effects on STAT
target gene expression.
Since the hierarchical clustering analysis showed large
differences in overall transcriptomes of Stat92Emat- and
Stat92E06346/+ embryos, we aimed to differentiate be-
tween canonical versus non-canonical JAK/STAT path-
way by analyzing significantly regulated probe sets of Jak
gain- (hopTum-l/+) and loss-of-function (hop3/+) and Stat
loss-of-function (Stat92E06346/+) separately from the ma-
ternal null (Stat92Emat-). For the putative canonical tar-
gets assessing overlaps among hopTum-l/+ upregulated,
hop3/+ downregulated and Stat92E06346/+ downregulated
genes, we found 221 putative probe sets and for the
putative non-canonical targets assessing overlaps among
hopTum−/+l upregulated, hop3/+ downregulated and
Stat92E06346/+ upregulated genes, we found 371 putative
probe sets (Fig. 2A). While comparing putative canonical
targets by assessing overlaps among hopTum-l/+ upregu-
lated, hop3/+ downregulated and Stat92E mat- downregu-
lated genes, we found 66 putative probe sets and for the
putative non-canonical targets assessing overlaps among
hopTum-l/+ upregulated, hop3/+ downregulated and
Stat92E mat- upregulated genes, we found another 66 pu-
tative probe sets (Fig. 2B). The total number of unique
probe sets for further analyses was 258 putative canon-
ical and 409 putative non-canonical probe sets (Add-
itional file 5: Table S4).
Non-canonical targets are significantly more enriched
with heterochromatin markers
Since the distinct mode of the non-canonical JAK/STAT
pathway involves heterochromatin stabilization by
unphosphorylated STAT by its interaction with HP1a,
we hypothesized that we would observe increased asso-
ciation of putative non-canonical target loci with key
heterochromatin markers, HP1a, Su(var)3–9 and
H3K9me3 [19, 26, 27, 29]. We therefore identified over-
laps with the publicly available modENCODE ChIP-seq
database annotating loci enriched with HP1a, Su(var)3–
9 and H3K9me3 in various wildtype background samples
at different developmental stages and Drosophila cell cul-
ture [56]. Among probe sets that were classified as
Fig. 2 Biologically relevant overlapping probe sets of putative canonical and non-canonical transcriptional targets inferred by microarray.
Significant genes were assessed for overlaps among the Jak-Stat mutants previously determined to be relevant for the canonical versus
non-canonical heterochromatin-mediated silencing mechanism [19, 26] for (a) embryo samples and (b) maternal null and embryo samples
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putative canonical targets by our transcriptional analyses,
25.6% had HP1a, Su(var)3–9 and/or H3K9me3 enriched
site overlap and 1.6% mapped to transposable elements,
compared to 35.9% and 2.2% respectively in non-
canonical targets. Our results comparing the putative ca-
nonical versus the putative non-canonical targets we iden-
tified from our transcriptome analyses thus indicate that
as expected, there was significant difference between these
two groups, in which the putative non-canonical tran-
scriptional target group had a larger number of overlap
sites with HP1a, Su(var)3–9 and/or H3K9me3, or are
transposable element sites, compared to the group classi-
fied as canonical transcriptional targets (38.1% versus
27.1%, p = 0.004 Fisher’s exact test) (Fig. 3).
Canonical and non-canonical targets have distinct bio-
logical roles
After having classified probe sets to canonical versus
non-canonical JAK/STAT pathway transcriptional target
genes, we sought the biological significance of these dif-
ferent targets. We used the DAVID Gene Ontology data-
base to determine biological functions and pathways that
are enriched for the canonical and non-canonical target
gene panel [57, 58]. Canonical targets appeared to be
mainly involved in development and innate immunity, as
expected for their well-established role, as seen by the
top 20 fold enrichment of GO Biological Functions
terms (Fig. 4). Ten out of 20 top enriched terms were
relevant to development, including “larval chitin-based
cuticle development,” “establishment of epithelial cell
apical/basal polarity,” “body morphogenesis,” “chitin-
based cuticle development,” “metamorphosis,” “negative
regulation of cell proliferation,” “chorion-containing egg-
shell formation,” “wing disc development,” “imaginal
disc-derived wing morphogenesis” and “multicellular or-
ganism reproduction.” Terms relevant to innate immune
response were also found four times, including “innate
immune response,” “response to bacterium,” “Toll sig-
naling pathway” and “defense response to Gram-positive
bacterium.” Other enrichment terms suggested a role for
the canonical pathway in olfactory and sensory response,
including “detection of chemical stimulus involved in
sensory perception of taste,” and “sensory perception of
smell.” Additional GO terms suggested transport mecha-
nisms, including, “microtubule-based process” and
“transmembrane transport” and others included “cellular
response to heat” and “proteolysis.”
On the other hand, non-canonical targets were
enriched mainly with terms relevant to metabolism, in-
cluding “glucose metabolic process,” “ecdysteroid meta-
bolic process,” “pyruvate metabolic process,” and stress
response including “detection of temperature stimulus
involved in thermoception,” “cold acclimation,” “thermo-
taxis,” “mechanosensory behavior,” and “cellular re-
sponse to oxidative stress.” Female sex and egg
development also appeared to be prevalent among the
GO enriched terms, including “imaginal disc-derived fe-
male genitalia development,” “eggshell chorion assem-
bly,” “vitellogenesis” and “vitelline membrane formation
involved in chorion-containing eggshell formation.”
Regulation of visual perception also appeared multiple
times including “compound eye retinal cell programmed
cell death,” “visual perception” and “deactivation of
rhodopsin mediated signaling.” “Regulation of G-protein
coupled receptor protein signaling pathway” was also
among the top fold enrichment. The observation that
the highest GO term fold enrichment was seen for
“negative regulation of RNA splicing” is noteworthy, and
may be related to the role of the non-canonical pathway
in epigenetic signaling. GO terms related to chorion for-
mation were found in both canonical and non-canonical
targets, suggesting that while a large number of target
Fig. 3 Non-canonical target sites have significantly more overlaps with heterochromatin sites. For both embryonic and maternal transcripts,
overlaps between genomic loci corresponding to the probe set annotation and HP1a, Su(var)3–9 and/or H3K9me3 enriched loci listed in the
relevant modENCODE database were tabulated. Probe sets annotated as transposable elements were also considered as heterochromatin sites.
Non-canonical target probe sets had significantly higher proportion of such heterochromatin-related sites compared to canonical targets
(p = 0.004, Fisher’s exact two-tailed test)
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loci distinct to canonical or non-canonical pathways
exist, there is also a possibility of shared processes and
targets.
Discussion
Our current study aimed to differentiate between canon-
ical versus non-canonical JAK/STAT target genes in
Drosophila by using a genome-wide transcriptional ana-
lysis approach. The use of the Drosophila system with a
simple JAK/STAT system that involves only one JAK
and one STAT with mutant lines readily available facili-
tated this current study that aimed to distinguish be-
tween the two pathways by transcriptional analysis. The
genetic analysis of the non-canonical JAK/STAT path-
way and the establishment of the paradigm of unpho-
sphorylated STAT as a key player in epigenetic
regulation in the nucleus has been conducted in Dros-
ophila [19, 26]. We therefore performed genome-wide
transcriptome analyses to characterize transcriptional
targets of relevant Jak and Stat mutants in this study.
Furthermore, we quantified overlaps with ChIP-seq
peaks of the major heterochromatin factors of HP1a,
Su(var)3–9 and H3K9me3 binding sites using available
modENCODE data. Our findings that putative non-
canonical transcriptional targets had significantly more
heterochromatin marker overlaps compared to the puta-
tive canonical targets given this study design supports
the notion that while canonical targets rely mainly on
classic signaling transduction modes to activate tran-
scriptional target genes via phosphorylated and dimer-
ized STAT, the non-canonical epigenetic mechanism via
unphosphorylated STAT operates in a distinct manner,
by its interaction with HP1a and heterochromatin asso-
ciated factors. Additional studies conducting chromatin
immunoprecipitation experiments in conjunction with
transcriptomic analyses using samples of the exact same
developmental stage would confirm the conclusions
drawn from this study.
Fig. 4 Canonical transcriptional targets are generally enriched with biological processes relevant to development and innate immunity, whereas
non-canonical transcriptional targets appear to be involved with metabolism. (a) Gene Ontology (GO) enrichment of Biological Processes terms
was assed using DAVID and the 20 highest fold enrichment GO terms and (b) all hits of KEGG pathway enrichment terms are shown for the ca-
nonical versus non-canonical target probe sets, in order of fold enrichment
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In flies and other organisms, HP1a-mediated hetero-
chromatin maintenance has been implicated as a regula-
tor of the aging process [28, 51]. A specific underlying
association between heterochromatin regulation, metab-
olism, aging and oncogenesis can be inferred from mul-
tiple studies in different organisms. In S. cerevisiae,
metabolism, genomic instability and cell life span
through replication have been linked to heterochromatin
[59]. Furthermore, it was found from a later study in
C.elegans, that mutants of the HP1a homologue, HPL-2
altered germline gene expression that controls the
switch to the dauer state, as well as longevity and lipid
metabolism [60]. These observations are consistent with
the GO term enrichment of the non-canonical JAK/
STAT pathway we observed in the current study, in
which we found among the highest fold enrichment,
gene groups related to various metabolic pathways,
stress response, the female genitalia and egg develop-
ment. It has been shown previously that unphosphory-
lated STAT can be protective against genome instability
and oncogenesis by its interaction with HP1a, and may
further suggest that the enrichment in various
metabolism-related genes we have observed especially in
the non-canonical heterochromatin-mediated pathway
may be related to the aforementioned links among these
various processes described in different species [27, 29].
Stress response terms were also frequently found to be
among the top 20 fold enrichment, mostly regarding
cold temperature sensing and response, as well as re-
sponse to oxidative stress. It has been shown previously
in Arabidopsis that epigenetic regulation of heterochro-
matin markers occur at repetitive elements in response
to cold-stress, as well as activation of transcription of
heterochromatic loci induced by stress [61, 62]. Further-
more, a link between oxidative stress and heterochroma-
tin stabilization has been described and shown to
provide genome protection [63]. It is also interesting to
note that the highest fold enrichment GO term found
among non-canonical targets was “negative regulation of
RNA splicing.” Considering the epigenetic role of the
non-canonical pathway, it is conceivable that addition-
ally to heterochromatin maintenance, the non-canonical
pathway may coordinate RNA splicing. In contrast to
the putative non-canonical targets where GO terms re-
lated to metabolism, stress response and female sex-
related terms were among the most enriched terms, GO
term enrichment of the canonical target gene group
were related to the well-established roles of the JAK/
STAT pathway, development and innate immune re-
sponse, as expected. Transcriptional regulation of genes
related to development and innate immunity by the
JAK/STAT pathway is known to be highly conserved
across species [12, 64]. Indeed, we found TotC and TotX
in our analyses of putative transcriptional target genes
inferred from the microarray and modEncode overlaps
(Additional file 5: Table S4). These observations provide
further support for the idea that our approach may be
effective in uncovering additional target genes, both ca-
nonical and non-canonical.
In this study, we utilized relatively young mutant em-
bryos laid between 0 and 12 h. On the other hand, the
modENCODE dataset that we inferred heterochromatin-
related factors varied, from early embryo to the late lar-
val stage of different genetic backgrounds, as well as
various cell lines. Our conclusions would therefore be
strengthened by additional experimental studies using
specific genetic backgrounds, same tissues and tempor-
ally regulated samples for further transcriptional ana-
lyses, coupled by chromatin immunoprecipitation of
relevant heterochromatin factors of the corresponding
samples. Such future studies would enable us to identify
additional targets, and perform an increasingly meticu-
lous analysis to differentiate between the canonical ver-
sus non-canonical JAK/STAT pathway. Nevertheless,
our current study supports the notion that canonical
versus non-canonical JAK/STAT pathway may regulate
numerous biologically distinct processes additionally to
some possible overlaps and it would be beneficial to
conduct further studies that establish methods that dis-
tinguish between the two pathways.
Conclusions
We conducted a genome-wide analysis comparing puta-
tive canonical versus non-canonical JAK/STAT pathway
transcriptional targets during early Drosophila develop-
ment. Our findings of differences between canonical ver-
sus non-canonical JAK/STAT pathway targets and
specific loci regulated across the genome give us insights
into the significant and distinct biological roles of each
that may exist, additionally to possible overlapping
targets.
Methods
Fly stocks/genetics and RNA sample preparation
All crosses were carried out at 25 °C on standard corn-
meal/agar medium. Fly stocks of w1118, hop3/FM7c,
Stat92E06346/TM3, FRT82B[ovoD1, w+]/TM3, and hopTum-
l/FM7c were obtained from the Bloomington Drosophila
Stock Center (Bloomington, IN). For the preparation of
heterozygous embryos, females from the mutant stocks
were crossed with w1118 males and the resulting hop3/+,
Stat92E06346/+ or hopTum-l/+ progeny were used to pro-
duce embryos, which were collected between 0 and 12 h
after egg laying on apple agar plates with yeast paste. To
generate Stat92Emat– embryos, hsp70-flp;
FRT82BStat92E06346/TM3 females were crossed to hsp70-
Flp; FRT82B[ovoD1, w+]/TM3 males. Third instar larval
progenies were heat-shocked at 37 °C for 2 h daily over
Tsurumi et al. BMC Genomics  (2017) 18:718 Page 7 of 10
3 to 4 days, and resulting adult females of the genotype
hsp70-flp; FRT82BStat92E06346/FRT82B[ovoD1, w+] which
were used to produce embryos lacking in maternal
Stat92E gene products, as described previously in the
dominant female-sterile “germline clone” technique [65].
Stat92Emat– and control w1118 were collected between 1
and 2 h after egg laying on apple agar plates with yeast
paste. The embryos were washed twice with deionized
water and total RNA was prepared using the RNeasy
Plus Mini kit (Qiagen) according to the manufacturer’s
manual. RNA quality was assessed using the Agilent
2100 Bioanalyzer and the RNA 6000 Nano kit (Agilent
Technologies Inc., Palo Alto, CA).
Microarray analyses
To prepare microarray samples from the RNA prepared,
200 ng of total RNA was used to prepare biotin-labeled
RNA using Ambion MessageAmp Premier RNA Ampli-
fication Kit (Applied Biosystems, Forster City, CA).
Briefly, the first strand of cDNA was synthesized using
ArrayScript reverse transcriptase and an oligo(dT) pri-
mer bearing a T7 promoter. Then DNA polymerase I
was used (in the presence of E. coli RNase H and DNA
ligase) to convert single-stranded cDNA into double-
stranded DNA (dsDNA), which was then used as a tem-
plate for in vitro transcription in a reaction containing
biotin-labeled UTP and T7 RNA Polymerase to generate
biotin-labeled antisense RNA (aRNA). Twenty μg of la-
beled aRNA was fragmented and 15 μg of the fragmen-
ted aRNA was hybridized to Affymetrix Drosophila
Genome 2.0 Array Chips according to the manufac-
terer’s Manual (Affymetrix, Santa Clara, CA). Array
Chips were stained with streptavidin-phycoerythrin,
followed by an antibody solution (anti-streptavidin) and
a second streptavidin-phycoerythrin solution, performed
by a GeneChip Fluidics Station 450. The Array Chips
were scanned with the Affymetrix GeneChip Scanner
3000. For the numerical conversion to expression inten-
sity and Present/Absent calls employing MAS5 [66]
(Additional file 1: Table S1), the Genespring software
(Agilent Technologies Inc., Palo Alto, CA) or the R
package Affy was used [67, 68]. R version 3.1.3 was used
for the analyses.
For each mutant genotype, control probe sets were fil-
tered, as well as those where the wild-type and respect-
ive mutant intensities all had the “Absent” call. The top
10th percentile upregulated and downregulated log2 fold
change of all probes were found to be 1.027 and −1.047,
respectively and therefore the 2-fold change cut-off was
considered to be significantly differentially regulated
genes for each mutant genotype (Additional file 2: Table
S2). Pearson’s correlation with complete distance separ-
ation was used for the clustering and heatmap represen-
tation of the differentially regulated probe sets. For
conducting RT-PCR, 0–12 h embryos were collected
and total RNA was harvarested using the RNeasy kit
(Qiagen). The SuperScript™ III Reverse Transcriptase kit
(Invitrogen) was used to generate cDNA as a template
for semi-quantitative PCR.
HP1a and Su(var)3–9 binding and the heterochromatic
H3K9me3 enriched sites were obtained from the pub-
licly available modENCODE ChIP-seq database for com-
parison with genomic sites associated with the relevant
probe sets identified from the microarray analysis [56].
The following modENCODE data files were used: for
HP1a binding sites, #3956 (OregonR 14–16 h embryo),
#323 (S2 cells), #955 (OregonR 3rd instar larvae), #2074
(S2 cells), #2665 (OregonR 2–4 h embryo), #2666 (BG3-
c2 cells), #2668 (S2 cells) and #3956 (OregonR 14–16 h
embryo), for Su(var)3–9 binding sites, #952 (BG3-c2)
and #2673 (S2), and for H3K9me3 enrichment, #971
(yellow cinnabar brown speck 0–4 h embryo) and #4939
(OregonR 14–16 h embryo). In our study, if one or more
enrichment sites were found to overlap with the anno-
tated genomic locus indicated by the microarray data,
the gene was deemed to be relevant to heterochromatin.
For the overlap between probe sets upregulated by hop-
Tum-l/+ and downregulated by hop3/+, probe sets overlap-
ping with downregulated Stat92E06346/+ was categorized
as putative canonical targets, whereas those upregulated
were categorized as non-canonical targets. Similarly, Sta-
t92Emat- was also analyzed by taking into consideration,
overlaps with hopTum-l/+ upregulated and hop3/+ down-
regulated probe sets. Probe sets where the Stat92E06346/+
and Stat92Emat- showed opposite trends were removed
from the analyses, as well as hopTum-l/+ and hop3/+ over-
laps without significant Stat92E06346/+ or Stat92Emat- dif-
ferential expression.
The two-tailed Fisher’s exact test was used to deter-
mine significance between the difference in the number
of probe sets for which their relevant sites overlapped
with HP1a, Su(var)3–9 and/or H3K9me3 enriched sites
and transposable elements comparing putative canonical
versus non-canonical targets. Database for Annotation,
Visualization and Integrated Discovery (DAVID), version
6.8 Beta was used for functional annotation and asses-
sing the top 20 Fold Enrichment of Gene Ontology
terms of putative canonical and non-canonical sets [57].
Additional files
Additional file 1: Normalized dataset. (XLSX 3589 kb)
Additional file 2: Significant up- and down-regulated fold change
probe sets of each mutant genotype. (XLSX 308 kb)
Additional file 3: Overlaps of significantly changed mutant probe sets
and putative canonical/non-canonical transcriptional target classification.
(XLSX 138 kb)
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Additional file 4: Fig. S1. Validation of transcriptional upregulation of
known target genes in hopTum/+ embryo samples. RT-PCR was conducted
on 0–12 h W1118 wildtype control, or hopTum/+ embryo collection to assess
the upregulation of previously known JAK-STAT target genes. (JPEG 27 kb)
Additional file 5: Heterochromatin marker modENCODE enrichment
and transcriptional target overlaps. (XLSX 56 kb)
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